Showing results (31-40 of 1,050) with videos related to
Sort By:
Pageof 105
Structure (London, England : 1993)|July 7, 2023
Major classes of neutralizing antibodies evaded by the SARS-CoV-2 Omicron variantMeng Yuan, Ian A WilsonImmunological Reviews|May 22, 2022
Protective neutralizing epitopes in SARS-CoV-2Hejun Liu, Ian A WilsonCurrent Pharmaceutical Design|October 29, 2009
Presentation of lipid antigens by CD1 glycoproteinsAndré Schiefner, Ian A WilsonCurrent Pharmaceutical Design|December 7, 2010
Structure-based vaccine design in HIV: blind men and the elephant?Robert Pejchal, Ian A WilsonProteins|June 4, 2014
Crystal structure of the C-terminal domain of mouse TLR9Bernard Collins, Ian A WilsonNature Communications|May 12, 2021
Single-component multilayered self-assembling nanoparticles presenting rationally designed glycoprotein trimers as Ebola virus vaccinesLinling He, Anshul Chaudhary, Xiaohe Lin, et al.Nature Communications|June 29, 2016
Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastabilityLeopold Kong, Linling He, Natalia de Val, et al.Nature Communications|May 17, 2023
Structural basis of epitope selectivity and potent protection from malaria by PfCSP antibody L9Gregory M Martin, Monica L Fernández-Quintero, Wen-Hsin Lee, et al.Retrovirology|June 3, 2014
Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunitsAnila Yasmeen, Rajesh Ringe, Ronald Derking, et al.Biorxiv : the Preprint Server for Biology|September 30, 2020
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibodyNicholas C Wu, Meng Yuan, Sandhya Bangaru, et al.Pageof 105